Created: 27th February 2013 | Last Updated: 24th April 2017
Introduction
|
Alopecia areata is a chronic inflammatory disease that affects the hair follicle causing patchy non-scarring hair loss on the scalp. Total loss of scalp hair is known as alopecia totalis, and loss of the entire scalp and body hair is known as alopecia universalis. |
Related chapters |
Aetiology
- Alopecia areata is probably an autoimmune disorder
- About 20% of patients have a family history
History
- The onset may be at any age with a peak incidence between the second and fourth decades
- There is no known race or sex preponderance
Clinical findings
- The characteristic initial lesion is a circumscribed, totally bald, smooth patch. The skin within the bald patch is normal or slightly reddened. There is no scarring
- Short broken hairs (exclamation mark hairs) are often seen around the margins of active expanding patches of alopecia
- Yellow dots can be seen around hair follicles
- Other hair-bearing areas of skin such as the beard can be affected. In some patients the eyebrows and eyelashes may be the only affected sites
- Subsequent progress is very varied; the initial patch may regrow within a few months, or further patches may appear after an interval of three to six weeks and then in a cyclical fashion. Sometimes a succession of discrete patches become confluent leading to a diffuse loss of hair
- Occasionally patients go on to lose all / almost all of their scalp hair (alopecia totalis) or their entire scalp and body hair (alopecia universalis)
- Nails are involved in 10% of patients referred for specialist advice, usually in the context of severe hair loss. Nail pitting is the most common finding, but some cases show a roughening of the nail plate or non-specific dystrophic changes
-
Other presentations
- Ophiasis is a well-defined pattern of alopecia areata when the hair loss is localised to the sides and lower back of the scalp
- In some cases the initial hair loss is more diffuse over all or part of the scalp
Images
Please click on images to enlarge, or choose to download. Images must only be used for teaching purposes and are not for commercial use. Notice and credit must be given to the PCDS and any other named contributor.
Management
General advice
- Provide a patient information leaflet
-
Prognosis
- Even in mild cases the condition will last many months
- Patient more likely to have a full regrowth of hair include those presenting with lesser degrees of hair loss. One study from Japan reported spontaneous remission within one year in 80% of patient with a small number of circumscribed patches of alopecia
-
The prognosis is less favourable in the following:
- More severe hair loss at the onset (and such patients are more likely to develop alopecia totalis or universalis, from which full recovery is less than 10%)
- Onset in childhood
- With ophiasis pattern
- Recurrence - most patients will have more than one episode of alopecia areata
- Counselling - some patients are profoundly upset by their alopecia and may require psychological support
Scalp treatment
A number of treatments can induce hair growth in alopecia areata but none have been shown to alter the long-term course of the disease
-
Topical steroids
- Very potent topical steroids eg Dermovate ® cream are widely used, and although the evidence for their effectiveness is limited they probably hasten regrowth of hair in some patients with mild to moderate disease
- Regrowth is likely to take several weeks / months, and begins with the growth of fine white hair
-
Intralesional steroids
- Can be given by intralesional injections just beneath the dermis or using a Dermajet ®, a needleless device, every 3-4 weeks. One of the most common drugs used is triamcinolone
- This method is best used for patchy hair loss. Larger areas of alopecia are less likely to respond
- The evidence for intralesional treatment is a little stronger than for topical treatment and so should be considered for patients failing to respond to topical steroids
-
Contact immunotherapy
- Is the repeated, topical application of contact allergens such as DPCP (2,3-diphenylcyclopropenone)
- Although up to 60% of patients in studies showed response to treatment, the degree of improvement varied widely from 9-87%
- Treatment should be stopped after six months if no response is noted
- Contact immunotherapy is perhaps best reserved for larger / more extensive patches of hair loss, which may have been unsuccessfully treated with intralesional steroids. Patients with extensive hair loss are less likely to respond
- Patients need careful counselling before having this treatment - contact eczema is the most common adverse effect. Uncommon adverse effects include urticaria and vitiligo, and other changes in skin colour especially in patients with darker skin
-
Other treatments
- Minoxidil ® has been used for scalp hair loss - the evidence for effectiveness is lacking
-
Secondary Care - for rapid / progressive hair loss a number of treatments have been used including systemic steroids, ciclosporin and methotrexate, however, side-effects are a major consideration and in patients with severe hair loss the response rate is probably too low to justify the risks in most such patients
Beard area, eyebrows and eyelashes
- Eyebrows can be treated with intralesional steroid injections
- Loss of eyelashes is very difficult to treat as topical steroids cannot be used at this site
-
Patients with alopecia affecting the beard should be advised to try and disguise the hair loss by shaving regularly. The use of potent / super-potent topical steroids could be considered although there is little evidence to support their use and patients need to be warned about the risks of steroid atrophy
Wigs and prosthesis
- Wigs, integrated hair systems, hats and false eyelashes can be used as effective ways to cope with alopecia areata
- Local dermatology departments may be the best contact in terms of obtaining / finding out where to obtain wigs on the NHS. Patients are given a choice of monofilament acrylic wigs or synthetic acrylic wigs. Human hair wigs are normally reserved for patients found on patch tests to be allergic to acrylic wigs
- For individuals with patchy alopecia there is the option to integrate a weft of human hair or use a top piece that is either clipped into surrounding hair or braided in
- The loss of eyebrows can be particularly challenging. Eyebrows can be drawn in using eyebrow pencil ink, or some organisations have developed semipermanent tattoos for eyebrows
Other resources
- Patient support groups - Alopecia UK
- British Association of Dermatologists Guidelines









